Skip to content
drillr.ai
Sign up

ORGO

Organogenesis Holdings Inc.

NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US

$1.71
+4.27%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-29.7%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Apr 24, 2026Grow Brian · officer: Chief Commercial OfficerM-Exempt958$1.24
Mar 11, 2026Leibowitz Arthur S · directorPurchase5,000$2.68
Mar 11, 2026Driscoll Michael Joseph · directorPurchase10,000$2.67
Feb 20, 2026Francisco David · officer: Chief Financial OfficerA-Award195,312$0.00
Feb 20, 2026Gillheeney Gary S. · director, officer: President and CEOA-Award507,795$3.84
Feb 20, 2026Cavorsi Robert · officer: Vice President, StrategyA-Award16,290$0.00
Feb 20, 2026Grow Brian · officer: Chief Commercial OfficerA-Award48,330$0.00
Feb 20, 2026Montecalvo Antonio S. · officer: Vice President, Health PolicyA-Award23,162$3.84
Feb 20, 2026Bilbo Patrick · officer: Chief Operating OfficerF-InKind16,212$3.84
Feb 20, 2026Duraibabu Prathyusha · directorA-Award48,828$0.00
Feb 20, 2026Freedman Lori · officer: Chief Admin. and Legal OfficerA-Award42,780$0.00
Feb 20, 2026Quintero Gilberto · directorA-Award48,828$0.00
Feb 20, 2026Bilbo Patrick · officer: Chief Operating OfficerA-Award120,267$3.84
Feb 20, 2026Bilbo Patrick · officer: Chief Operating OfficerA-Award48,612$0.00
Feb 20, 2026Francisco David · officer: Chief Financial OfficerA-Award43,602$0.00
Feb 20, 2026Francisco David · officer: Chief Financial OfficerA-Award111,358$3.84
Feb 20, 2026Cavorsi Robert · officer: Vice President, StrategyA-Award53,452$3.84
Feb 20, 2026Lustig Garrett · directorA-Award48,828$0.00
Feb 20, 2026Gillheeney Gary S. · director, officer: President and CEOA-Award890,625$0.00
Feb 20, 2026Freedman Lori · officer: Chief Admin. and Legal OfficerF-InKind14,267$3.84
Feb 20, 2026Cavorsi Robert · officer: Vice President, StrategyF-InKind5,432$3.84
Feb 20, 2026Driscoll Michael Joseph · directorA-Award48,828$0.00
Feb 20, 2026Montecalvo Antonio S. · officer: Vice President, Health PolicyA-Award11,218$0.00
Feb 20, 2026Giacomin Jon L · directorA-Award48,828$0.00
Feb 20, 2026Bilbo Patrick · officer: Chief Operating OfficerA-Award210,937$0.00
Feb 20, 2026Leibowitz Arthur S · directorA-Award48,828$0.00
Feb 20, 2026Francisco David · officer: Chief Financial OfficerF-InKind14,541$3.84
Feb 20, 2026Montecalvo Antonio S. · officer: Vice President, Health PolicyF-InKind3,741$3.84
Feb 20, 2026Korfin Michele Ilene · directorA-Award48,828$0.00
Feb 20, 2026Montecalvo Antonio S. · officer: Vice President, Health PolicyA-Award40,625$0.00
Institutional positioning

13F filings over the trailing two quarters

New 18Increased 36Reduced 50Sold out 118
FilerActionSharesFiled
MORGAN STANLEYReduced11,616,795May 15, 2026
SOLEUS CAPITAL MANAGEMENT, L.P.Increased10,085,951May 14, 2026
BLACKROCK, INC.Increased4,899,751May 13, 2026
FIRST LIGHT ASSET MANAGEMENT, LLCReduced3,498,533May 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position2,900,816May 15, 2026
DIMENSIONAL FUND ADVISORS LPIncreased2,891,006May 7, 2026
D. E. SHAW & CO., INC.Increased2,297,974May 15, 2026
ASSENAGON ASSET MANAGEMENT S.A.Reduced1,967,952Apr 20, 2026
GEODE CAPITAL MANAGEMENT, LLCReduced1,783,964May 15, 2026
DEUTSCHE BANK AG\Reduced1,705,681May 6, 2026
ACADIAN ASSET MANAGEMENT LLCIncreased1,576,645May 13, 2026
STATE STREET CORPIncreased1,525,108May 15, 2026
VANGUARD PORTFOLIO MANAGEMENT LLCNew Position1,449,092May 8, 2026
RENAISSANCE TECHNOLOGIES LLCIncreased1,068,538May 14, 2026
AQR CAPITAL MANAGEMENT LLCIncreased881,717May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Apr 24, 2026